Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy: (90)Y Radioembolization for BCLM

PURPOSE: The purpose of this open-label, retrospective report was to determine the safety and effectiveness of locoregional therapy with yttrium-90 ((90)Y) radioembolization for patients with progressing breast cancer liver metastases (BCLM) despite polychemotherapy. MATERIALS & METHODS: Seventy...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Vasc Interv Radiol
Prif Awduron: Gordon, Andrew C., Gradishar, William J., Kaklamani, Virginia G., Thuluvath, Avesh J., Ryu, Robert K., Sato, Kent T., Gates, Vanessa L., Salem, Riad, Lewandowski, Robert J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4720166/
https://ncbi.nlm.nih.gov/pubmed/25156827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvir.2014.07.007
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg